The GAD-7 and the Beck Anxiety Inventory both measure anxiety, and they measure different halves of it. The GAD-7 is about worry, restlessness, and cognition. The BAI is about the body: racing heart, trembling, dizziness, difficulty breathing. Fifteen of its 21 items are physiological.
That split is not academic. A patient with constant rumination and few physical symptoms can score high on the GAD-7 and low on the BAI, and a patient with panic attacks but little cognitive worry will often produce exactly the reverse profile. The two are not interchangeable, and a low score on one is not reassurance about the other.
What each instrument captures
The GAD-7 was designed for primary care screening and maps directly onto DSM criteria for generalized anxiety disorder. Seven items cover worry, trouble relaxing, restlessness, irritability, and fear that something awful will happen. Patients rate the past two weeks on a 0-3 scale, giving a total of 0-21. At the standard cutoff of 10, sensitivity is 89% and specificity 82% for GAD (Spitzer et al., Arch Intern Med, 2006). Administration takes two minutes.
The BAI was developed in psychiatric outpatient settings, for a different job: separating anxiety from depression. Its 21 items lean heavily somatic. Numbness, hot flashes, wobbliness, pounding heart, choking sensations, trembling hands, faintness. Patients rate the past week, giving a total of 0-63.
Its accuracy is uneven across disorders, and that unevenness is the whole point of choosing it deliberately. It screens well for panic disorder and separates patients with panic from those without, but performs considerably less well for social phobia and OCD, where the defining features are cognitive or behavioral rather than physiological (Leyfer et al., J Anxiety Disord, 2006).
Neither instrument is diagnostic. Both quantify severity and flag patients for further assessment, and the diagnosis comes from the interview.
Key differences
Symptom focus. The GAD-7 captures worry and rumination. The BAI captures physical arousal, which in practice means it measures panic-like symptoms. Neither covers both domains, which is why the BAI is sometimes paired with the Penn State Worry Questionnaire.
Diagnostic utility. GAD-7 items match GAD criteria and predict GAD specifically. The BAI aligns with no single disorder, because it was built to separate anxiety from depression rather than to identify which anxiety disorder is present. It is most accurate for panic and least accurate for social anxiety and OCD.
Cost. The GAD-7 is public domain. The BAI is licensed through Pearson, so it carries a per-use cost that recurs for as long as you use it.
Medical confounding. The BAI's somatic focus becomes a liability in patients with cardiac, respiratory, or neurological disease, because a patient with COPD will honestly endorse breathlessness and dizziness that have nothing to do with anxiety. The score goes up. The anxiety has not. GAD-7's cognitive items sidestep the problem entirely.
Depression discrimination. The BAI was designed to minimize depression overlap by staying physical. The GAD-7 includes irritability and restlessness, which blur the line in patients carrying both.
When to use GAD-7
For most clinical contexts, the GAD-7 is the default choice. It's free, brief, validated extensively in primary care, and built into most EHR systems. Quality measures and payer requirements typically specify GAD-7 for anxiety screening.
Use it for routine primary care screening, GAD assessment, and treatment monitoring. A 4-point change is the usual minimal clinically important difference (Toussaint et al., J Affect Disord, 2020), though the authors are explicit that the figure wants replication in other populations. Treat smaller movements as noise.
For even quicker triage, the GAD-2, the first two items, works as an ultra-brief screener. A score of 3 or higher triggers the full GAD-7.
When to use BAI
The BAI makes sense when panic or somatic anxiety is the clinical focus, which is where its accuracy is strongest. It also earns its cost when the intervention targets physiological arousal directly, through relaxation training, breathing work, or biofeedback: those treatments move the somatic items first, and the GAD-7 will lag behind them.
It is also the right choice when separating anxiety from depression is the diagnostic question, or when a research protocol requires it for comparability.
Avoid it when cost or time is tight, when medical comorbidity would confound the somatic items, or when a quality measure names the GAD-7. It is the wrong tool for social anxiety, OCD, and worry without a physical component.
Using both instruments
Some evaluations warrant both. At intake the pair gives full coverage, cognitive from the GAD-7 and somatic from the BAI, and when treatment targets worry and arousal at once, running both is the only way to see which half is actually moving.
Disagreement between them is the useful result. High GAD-7 with low BAI suggests worry-predominant anxiety, which tends to respond to cognitive approaches. The reverse points toward the panic spectrum. Different problem, different treatment.
Practical considerations
GAD-7 is already integrated into most EHR systems. BAI often requires custom setup or separate administration. Both are generally well-accepted by patients, though BAI's physical-symptom focus may feel more comfortable for people who don't identify as "anxious" but acknowledge bodily symptoms.
In older adults and in medically complex populations the confounding compounds, since the base rate of genuine somatic symptoms rises with every additional diagnosis. GAD-7's cognitive focus gives cleaner data whenever a physical symptom has more than one plausible explanation.
---
For most providers the GAD-7 handles screening and monitoring on its own. Reserve the BAI for the three questions it answers better than anything else: panic, somatic anxiety, and telling anxiety apart from depression. The PHQ-9 pairs with either when depression co-occurs, which it usually does.